These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6662879)

  • 1. Gas chromatographic determination of oxprenolol in human plasma.
    Sioufi A; Colussi D; Mangoni P
    J Chromatogr; 1983 Nov; 278(1):185-8. PubMed ID: 6662879
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of oxprenolol in human plasma by high-performance liquid chromatography, in comparison with gas chromatography and gas chromatography-mass spectrometry.
    Godbillon J; Duval M; Gosset G
    J Chromatogr; 1985 Dec; 345(2):365-71. PubMed ID: 4086604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of oxprenolol in human blood plasma by gas chromatography].
    Nambara T; Akiyama S; Kurata M
    Yakugaku Zasshi; 1973 Apr; 93(4):439-41. PubMed ID: 4738513
    [No Abstract]   [Full Text] [Related]  

  • 4. Simplified method for the determination of oxprenolol and other beta-receptor-blocking agents in biological fluids by gas-liquid chromatography.
    Degen PH; Riess W
    J Chromatogr; 1976 Jun; 121(1):72-5. PubMed ID: 6483
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved electron-capture GLC determination of alprenolol and oxprenolol in serum using a wall-coated open tubular column.
    DeBruyne D; Kinsun H; Moulin MA; Bigot MC
    J Pharm Sci; 1979 Apr; 68(4):511-2. PubMed ID: 438982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gas chromatographic determination of metoprolol in human plasma.
    Sioufi A; Leroux F; Sandrenan N
    J Chromatogr; 1983 Jan; 272(1):103-10. PubMed ID: 6841530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of oxprenolol in plasma by column liquid chromatography.
    Devi KP; Rao KV; Baveja SK; Fathi M; Roth M
    J Chromatogr; 1988 Apr; 426(1):229-33. PubMed ID: 3384876
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorimetric determination of oxprenolol in plasma by direct evaluation of thin-layer chromatograms.
    Schäfer M; Mutschler E
    J Chromatogr; 1979 Oct; 164(2):247-52. PubMed ID: 541417
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of oxprenolol and its glucuronide metabolite in plasma and urine using high-performance liquid chromatography.
    Gluth WP; Sörgel F
    Pharmazie; 1991 May; 46(5):336-9. PubMed ID: 1896479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple inverse isotope dilution assay for the stereospecific determination of R(+)- and S(-)-oxprenolol in biological fluids.
    Dieterle W; Faigle JW
    J Chromatogr; 1983 Apr; 259(2):311-8. PubMed ID: 6343408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gas chromatographic analysis of alprazolam in plasma: replicability, stability and specificity.
    Greenblatt DJ; Javaid JI; Locniskar A; Harmatz JS; Shader RI
    J Chromatogr; 1990 Dec; 534():202-7. PubMed ID: 2094707
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple inverse isotope dilution assay for oxprenolol and nine metabolites in biological fluids.
    Dieterle W; Faigle JW
    J Chromatogr; 1983 Apr; 259(2):301-10. PubMed ID: 6343407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of oxprenolol in biological fluids using high-performance liquid chromatography.
    Tsuei SE; Thomas J; Moore RG
    J Chromatogr; 1980 Jan; 181(1):135-40. PubMed ID: 7364908
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects.
    Bradbrook ID; Babiker M; Crome P; Gillies HC; Morrison PJ; Rogers HJ; Shotton P
    Br J Clin Pharmacol; 1986 Apr; 21(4):371-6. PubMed ID: 3707811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of oxprenolol plasma concentrations in young female volunteers following oral administration of an oxprenolol Oros dosage form.
    Jack DB; Kendall MJ; Laugher SJ; Smith SR
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):185S-190S. PubMed ID: 4005121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxicologic analysis of some adrenergic-beta blockers in the diagnosis of intoxications].
    Wachowiak R; Tezyk A
    Arch Med Sadowej Kryminol; 2003; 53(4):289-99. PubMed ID: 14971294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxprenolol placental transfer, plasma concentrations in newborns and passage into breast milk.
    Sioufi A; Hillion D; Lumbroso P; Wainer R; Olivier-Martin M; Schoeller JP; Colussi D; Leroux F; Mangoni P
    Br J Clin Pharmacol; 1984 Sep; 18(3):453-6. PubMed ID: 6487485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative bioavailability of different oral sustained release oxprenolol tablets.
    Leucuta SE; Follidis M; Capalneanu R; Mocan A
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):178-84. PubMed ID: 9725478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of age on the pharmacokinetics of oxprenolol.
    Kendall MJ; Quarterman CP
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):101-4. PubMed ID: 7068281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inflammatory disease on plasma oxprenolol concentrations.
    Kendall MJ; Quarterman CP; Bishop H; Schneider RE
    Br Med J; 1979 Aug; 2(6188):465-8. PubMed ID: 158402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.